FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED

(603363)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-12
16.92 CNY   -3.31%
04/29Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/14Fujian Aonong Biological Technology Group Incorporation Limited announced that it has received CNY 1.439999989 billion in funding from Xiamen Aonong Investment Co., Ltd., Yuze Investment Partnership (Limited Partnership) and another investor
CI
2021China's Food Sector Posts 4% Jump in January-October Profit
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Results for the Nine Months Ended September 30, 2021

10/29/2021 | 04:48am EDT

Fujian Aonong Biological Technology Group Incorporation Limited reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 13,322.02 million compared to CNY 7,334.95 million a year ago. Revenue was CNY 13,322.02 million compared to CNY 7,334.95 million a year ago. Net loss was CNY 502.87 million compared to net income of CNY 502.27 million a year ago. Basic loss per share from continuing operations was CNY 0.78 compared to basic earnings per share from continuing operations of CNY 0.85 a year ago.


ę S&P Capital IQ 2021
All news about FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED
04/29Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Result..
CI
04/14Fujian Aonong Biological Technology Group Incorporation Limited announced that it has r..
CI
2021China's Food Sector Posts 4% Jump in January-October Profit
MT
2021FUJIAN AONONG BIOLOGICAL TECHNOLOGY : 603363) dropped from S&P Global BMI Index
CI
2021Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Result..
CI
2021Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Result..
CI
2021China's Food Sector Posts 10.7% Growth in Value-Added Industrial Output in January-May;..
MT
2021Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Result..
CI
2021Fujian Aonong Biological Technology Group Incorporation Limited announced that it expec..
CI
2021Fujian Aonong Biological Technology Group Incorporation Limited Reports Earnings Result..
CI
More news
Financials
Sales 2022 23 489 M 3 460 M 3 460 M
Net income 2022 -292 M -43,0 M -43,0 M
Net Debt 2022 - - -
P/E ratio 2022 -39,3x
Yield 2022 -
Capitalization 11 644 M 1 715 M 1 715 M
Capi. / Sales 2022 0,50x
Capi. / Sales 2023 0,31x
Nbr of Employees 12 386
Free-Float 44,4%
Chart FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED
Duration : Period :
Fujian Aonong Biological Technology Group Incorporation Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FUJIAN AONONG BIOLOGICAL TECHNOLOGY GROUP INCORPORATION LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 16,92
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
You Lin Wu Chairman & General Manager
Ze Sen Huang Chief Financial Officer & Deputy General Manager
Qing Qi Wen Chairman-Supervisory Board
Zu Yun Xue Independent Director
Chu Duan Wang Independent Director